Financial Architects, Inc Bausch Health Companies Inc. Transaction History

Financial Architects, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$14.88 - $20.13 $22,320 - $30,195	-1,500 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$12.98 - $30.25 $6,490 - $15,125	500 Added 50.0%	1,500 $23,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $27,390 - $46,240	-1,450 Reduced 59.18%	1,000 $30,000
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $9,234 - $11,902	450 Added 22.5%	2,450 $62,000
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $40,460 - $52,580	2,000 New	2,000 $49,000
Q1 2019 May 03, 2019	SELL	$20.23 - $26.29 $20,230 - $26,290	-1,000 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$20.64 - $25.67 $20,640 - $25,670	1,000 New	1,000 $26,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.96B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.